CLINICAL EXPERIENCE WITH IMIPRAMINE (G 22355) IN THE TREATMENT OF DEPRESSION 2
A. M. MANN, M.D., AND A. S. MACPHERSON, M.D.l The search for a chemical agent capable of modifying or reversing the mood disturbance and behavioral constellation characteristic of the clinically recognized depressive state has been carried out with greater or lesser degrees of enthusiasm for a considerable period of time. A wide range of agents has been utilized with rather unrewarding results, at least until quite recently. Presumably, underlying these attempts has been the belief that, notwithstanding the psychopathological and dynamic formulations which seem in many cases to have considerable pertinence, many of the features of the classical depressive syndrome -whether one labels such conditions as "endogenous", "involutional", "psychotic", or uses other descriptive terms -have as an underlying sub strata an organic disequilibrium, be this disequilibrium primary or secondary, whose exact basis is unestablished with any degree of certainty.
Lehmann" has recently reviewed some of these physio-chemical methods and points out that, with the possible exception of iproniazid, "none of these has been as reliable and prompt in action as electroconvulsive therapy".
Yet there seems little doubt that ECT, though of proven efficiency, is a treatment not without hazard to the patient, not only with respect to the incidence of physical complications, but also in terms of the not inconsiderable psychological and administrative hazards, chief among which are the troublesome questions of memory loss, the connotations of the word "shock", and the number of trained personnel required to carry out this form of treatment.
This type of problem is perhaps even more sharply delineated in private practice and in general hospital psychiatry than in a mental hospital setting; hence, any drug which shows reasonable promise of obviating these difficulties seems likely to arouse great interest and stimulate further research.
One of the most recently developed agents in this field is Imipramine (G 22355), evaluation of whose effects on a general hospital service and out patient basis forms the content of this paper.
This drug has been fairly intensively tested in Switzerland by Kuhn-and associates, while Lehmann" and Azima-have reported their investigations in Canada. Its pharmacological characteristics have been detailed elsewhere and need not be repeated here.
Guided by the favorable results of these investigators, it was decided to make a clinical evaluation of its possibilities on a general hospital psychiatric population and on an office or out patient basis.
There is a very understandable (and sometimes almost irresistible) tendency to make certain statements regarding the efficacy of a given preparation, procedure or technique in the field of human behavior without due regard for the possibility of other extraneous influences having come into play to produce the given result. If one's results are not to be left purely at the mercy of fortuitous circumstances, such possibilities should be carefully screened and discussed and their significance kept in mind.
The present study is by no means free of such difficulties, and it may be --- sound to discuss some of these factors in detail before dealing with the results of our evaluation.
All patients referred to in this investigation were treated either at one of the various subdivisions of the Department of Psychiatry of the Montreal General Hospital, or on an office basis privately by one of the authors. With the exception of a very few cases quoted for special features, all came under the direct treatment responsibility of one of us, usually as the treating psychiatrist, but occasionally as a supervising psychiatrist. Evaluating drug action on a population of this type is fraught with even more potential sources of error than a mental hospital patient group or volunteer subjects in a psycho-physiological laboratory.
The following represent some of the major sources of error in a population of this kind. 1) The time factor. In a general hospital setting there is the problem of the need for rapid turnover, with its allied feeling that treatment should take precedence over investigation.
2) The economic factor. This brings into play the parallel considerations of motivation for recovery being greater, and the question of the superior personal and family resources which may intercede on the patient's behalf to aid in recovery and cloud the investigative picture somewhat.
3) The differences in the patient group. Briefly, it would appear that there is a tendency to see patients who are somewhat less depressed than those seen in a mental hospital setting and that diagnostic categories are sometimes different. 4) The well-known fact of improvement -though often temporarily -ensuing merely from hospitalization per se. 5) The fact that there is more individual treatment responsibility than in a closed (or public) setting where the patient may be personally seen and interviewed closely and serially by several staff psychiatrists and where frequent conferences may be held on the particular patient. Hence, a more accurate rating as to diagnosis and severity of illness may be obtained in the latter type of setting. 6) On out-patients, environmental circumstances, family attitudes, etc., may alter as the disease progresses or recedes and this in itself may be a contributing factor in an individual's' progress or lack thereof. Further, if the patient is working, and able to stay at work, a slight betterment of ego functioning may set up a circular pattern of activity where the patient feels more gratified and is able to produce better work which in turn tends to make the clinical picture more favourable than it might have been in another setting. 7) The problem of controls. The lack of valid controls is a cogent argument which can be directed at much behavioral research. This is obviously not the place to launch a full-scale discussion of this thorny problem. However, one may say that often this "handicap" of lack of controls may be more apparent than real; further, the difficulties of really satisfactory controls may be so great that even the most elaborate "matching" attempts may be doomed to failure. In our study we felt that patients in many instances were their own controls, in the following ways; (a) From the knowledge of the disease process from which these patients suffered, one can reasonably accurately determine what might or should have been the "natural" course of the disease;
(b) The fact that many of these patients had had previous treatment by other means and had either failed to respond or had had relapses provides us with a type of control; and (c) Extensive experience gained in the field of depressive illnesses should allow an investigator to feel that his clinical assessment of results need not be entirely inaccurate. 8) Finally, there is always the problem of the enthusiasm of the investigators for a new weapon in the therapeutic armamentarium; this zeal may result in the patient being more vigorously treated and followed than he ordinarily would have been, and also brings into play the potent element of suggestion. Bearing in mind all the above-mentioned difficulties which we have purposely detailed at some length, we have attempted to take all these factors into consideration as much as possible under the circumstances. Further, we have deliberately oriented the study along clinical lines, feeling that in the final analysis if the drug concerned is to have any efficacy as a treatment procedure, it will be used by people who are engaged in the day-to-day practice of psychiatry, without the rigid controls, "double blinds", etc., of strictly investigative methods. Perhaps, then, our results may have some merit in terms of the values set upon them by actual clinical practice.
PROCEDURE
Seventy cases are here reported, 50 females and 20 males, having as their common feature the presence of varying degrees of depressive symptomatology. Twenty-seven were treated only as out ptaients; the remaining 53 were treated in hospital and then followed as out patients. The intensity of the depressive iHness was rated as mild, moderate, or severe on the basis of a rating procedure approximating that of Lehmann" et al. Seventeen patients (24%) were rated as "mildly depressed", 27 patients (39%) as "moderately depressed", and 26 patients (37%) were rated as "severely depressed". Diagnostically, these were classified as shown in Table I . Some remarks about nomenclature may be in order. The terminology used was, of necessity, that of the APA "new" classification, which is the system in use in the hospital. This new nomenclature, while generally a useful clarification of terms, is felt by many to be somewhat less than clear with regard to the depressive syndromes, viz., 1. It is evident from the above table that the diagnosis of "neurotic depressive reaction" predominates (57% of cases). Technically, this term has both qualitative and quantitative implications; it may mean what was commonly understood by "reactive depression" but in this study we also use it in a sense which is really synonomous with the older terms such as "involutional melancholia", and it is to be noted that the borderline between "depressive reaction", "psychotic depressive reaction" and "involutional psychotic reaction" is very ill-defined. Experience tends to point to the fact that a "depressive reaction" in a patient over 40 years of age, with a basically obsessive-compulsive personality structure may, if allowed to continue untreated for even a short period of time, become a "psychotic depressive reaction" or "involutional psychotic reaction". Hence, for purposes of communication, the vast majority of patients of this diagnosis may be thought of as "involutional melancholiacs" in the usual sense of the word, though without well-marked delusions and/or hallucinations.
2. The incidence of "manic depressive reaction" is low. This is not as much a peculiarity of the nomenclatural system as it is a reflection of different diagnostic standards in general hospital psychiatry as compared with mental hospital settings.
3. The use of the term "depressions with organic brain disease" refers to a category of patients with mild to moderate memory disturbances and other changes associated with cerebral arteriosclerosis. No actual confusional states exist in this group.
The average age of the patient group was 48.3 years. The range was 22 to 74 years. Twenty-five patients (35%) had had previous treatment for depression, either with unsuccessful results or with recurrence of symptomatology. The duration of depressive symptomatology of the patient group ranged from three weeks to thirteen years. The commonest finding seems to be that the illness had been present in mild or masked form for about a year and had become more acute or unbearable for the period two to three months prior to the initiation of treatment.
The dosage schedule was, almost invariably, to start at 50 mgm t.i.d. by mouth and after two days to increase this to 50 mgm q.i.d. The first dozen patients in the series were given intra-muscular dosages but this plan was discarded after it appeared that no significant differences in action could be noted. Only in four patients in this series did dosage level exceed 200 mgm per day and the highest dosage level was 300 mgm per day. We felt that 200 mgm was probably the optimum dosage level. Table II illustrates our gross results. The assessment of improvement was again rated in accordance with the scale designed by Lehmann et al, and in addition ito this our clinical ratings were supplemented by special nursing notes, relatives' statements, and other psychiatrists' opinions when available. We do not categorize our patients in terms of numbers of weeks of treatment as we found it impracticable to assess results under three weeks. As can be seen, about 63% of the patients were considered either "recovered" or "much improved". If one included the "improved" group, this figure rises to 81%. 
RESULTS
These figures conform very closely to those arrived at by other investigators in different settings. Of those patients who were "unimproved" or "worse", two were on the drug only two days and would not continue to take it because of the overwhelming side effects. (See below.) In general, it may be said that the group showing the best and most dramatic clinical response were those patients with well-delineated, severe classical depressive states in the involutional age group.
It is noted that some of our patients had concomitant sub coma insulin therapy. This we did not consider of major importance in the evaluation of results.
Perhaps a more important consideration is the concomitant use of electroconvulsive therapy which occurred in 15% of our cases. ECT in our series was given only when the admitting signs and symptoms were of such severity as to entail a severe suicidal risk, or when the patients were so delusional that one could not conscientiously await the effect of imipramine, or again in certain cases where there was very marked agitation. The standard practice in this regard was to initiate both modalities of therapy on admission and when the patient had received two or three ECT, discontinue this form of treatment and use only Imipramine.
Our findings tend to bear out other investigators' reports of the relatively slow onset of action (averaging at least one week). We have also found it useful, where agitation was pronounced, to make simultaneous use of chlorpromazine, although agitation as a side effect was not marked in our series. Indeed Imipramine tended to diminish, in most cases, the agitation associated with depression.
It was also our impression that there was an inverse relationship between the presence of definite so-called "reactive factors" and the degree of improvement. It is also to be noted that depressions in the age group under 40 did not, on the whole, do well with this drug. Paralleling this is our feeling that where the depressive symptomatology appears to be "built-in", so to speak, as a part of character structure, the drug did not appear to effect any real improvement.
Clinically, we were most interested in observing the lifting of depression in hospitalized patients without the memory loss that would have ensued from the number of ECT which would have been required to effect the same type of result, and this has some interesting ramifications. We felt that the recovery process of these patients appeared to be speeded up once the initial anti-depressive effect of the drug had set in by the fact that they were able to talk more spontaneously and freely, and much more able to accept psychotherapeutic insight into their difficulties. This is an important consideration in view of the "blotting out" effect often seen with ECT. It was also felt that the patients who responded well to this' drug tended to be able to readjust themselves to their work situation considerably better. It had been our experience in the past that the patient who had had a good result in hospital would then find himself back at work, clinically "well", while there was still some impairment of memory for his work situation and for the precipitants and onset of illness. In a compulsive individual, we have often noted a prolongation of the secondary effects of the illness in this way.
Our out-patients, on the whole, represented the less severely depressed group. It was felt that the major contribution this drug made in this group of patients was to keep them functioning at work or in the home when otherwise hospitalization would have been imperative. In several of this group ECT had been previously used and it was noted that not only was the use of ECT avoided in these people, but the recurrence of the presenting symptomatology was cleared up in a considerably shorter period of time than in the previous attack. This group also included several cases who had proven refractory to ECT and who were living a most uncomfortable, barely-functioning existence, but who were not hospitalized because they were considered refractory to the usual forms of therapy. One such patient stated after two weeks on the drug that he felt "like myself again for the first time in six years".
Maintenance dosage seems to be a very important factor. All patients in our series who showed favourable results were continued on maintenance doses ranging from 50 mgm per day to 150 mgm per day, with the majority of patients taking 75 mgm per day. It is to be noted that the one definite recurrence in our series came as a result of premature removal of the drug. This patient had had an excellent result after four weeks of treatment and had, against advice, stopped maintenance doses two weeks after leaving hospital. He almost immediately began to feel somewhat worse and after two more weeks reported with an obvious and classical recurrence. In general it can be said that if patients have been "well" (and here we are referring to the "recovered" or "much improved" group) for three months, then it is safe to allow a decreased maintenance dose, but we have been very conservative in discontinuing the drug. Most of our "good result patients" took the drug for at least three months after they were considered well. The following case summaries are selected as being illustrative of results, both favourable and unfavourable, of treatment. Case 1. Miss G.F., a 52-year-old spinster, was admitted to hospital with depressive symptomatology dating back some six months or more. She had previously been hospitalized for medical investigation which had proven essentially negative, and had refused psychiatric referral at that time. She complained of early morning waking, showed diurnal fluctuation of mood, anorexia, weight loss, disinterest, inability to concentrate, great dissatisfaction and guilt over her work record and her interpersonal relationships, and was convinced that she could not hold her job. Psychomotor retardation was noted along with the presence of definite suicidal trends. She cried easily and was almost unable to communicate when first seen. She was treated in hospital with daily dosage level of 50 mgm t.i.d, by mouth, along with sub coma insulin. Psychotherapy was attempted but only very superficial contact could be made in this area. After an initial waiting period of about one week, the patient began to sleep through the night without sedation and could again read and concentrate. She began to take more interest in her appearance and was seen to be socializing well with other patients. The mood change was noted to be quite pronounced seven to ten days after the initiation of treatment and she reported a renewed zest for living and for returning to her work. She was kept in hospital for three weeks and by the time of discharge the dose had been reduced to 100 mgm per day in divided doses. She abandoned her plans for retirement, and was able to approach her employer directly about certain things that she had been unable to deal with in the work situtaion. On follow-up she continued to report improvement and stated "I feel like I did 25 years ago". Case 2. Mrs. M.W., age 60. The patient had had two previous psychiatric admissions for depression, one of them to a mental hospital. On the present admission she was judged to be markedly depressed and was hallucinating. She had been unable to function adequately for some three months, had lost 15 pounds, and had become a severe management problem. Precipitating factor was thought to be the birth of a grandson and consequent disruption of the patient's relationship with her daughter on whom she is very dependent. Agitation, guilt feelings, delusions of unworthiness and financial disaster were noted. She had previously received ECT and on this admission was first treated with ECT, receiving 13 treatments without any evidence of improvement. She was then placed on Imipramine in the usual dosage range. Her response was unusual in that improvement was noticed within three days of administration of the drug. The first noticeable change was that one could communicate with the patient where previously this was almost impossible. Gradual but very marked improvement continued with complete disappearance of symptoms in just over three weeks. She was discharged on a daily maintenance dose of 150 mgm.
Case 3. This 67-year-old woman was admitted to hospital for investigation of gastro-intestinal symptoms. From the history and the course in hospital it became apparent that regardless of the organic pathology (diverticulosis and possible carcinoma), there was a serious depressive illness present as well. This was partially in reaction to her husband's death two years ago and in reaction to her son's difficulties with his wife. In addition, there were many typical endogenous features. She showed no interest in getting well, wanted and needed a good deal of nursing care, was constantly pre-occupied with her bowels, felt weak, cried easily, and had no interest in life. On routine dosage of Imipramine her sleep became regular, her psychomotor activity increased markedly, and there was decreasing preoccupation with bowel function, and the development of a wish to leave hospital and to take up her duties. Her medical condition is still a serious one, but the patient's adjustment to life has continued to be remarkably good. She is on a maintenance dose of 150 mgm. Despite the further investigation which will be required for her diverticulosis, she can make plans, think in terms of the future, concentrate well, and has no trace of the former depressive symptomatology. with a very chronic history of somatic complaints for which no organic cause had ever been ascertained. Her husband stated that she had been completely unable to cope with the work of the house or take care of the children for at least five years. Considerable money had been spent in many medical and psychiatric centres for diagnosis and treatment with little or no response. Patient had, by this time, complaints which could only be regarded as somatic delusions and which tended to mask a very strong affective disorder. Little hope was held for the possibility of improvement, but it was noted that about one week after being placed on the usual dosage of Imipramine a dramatic change had occurred in the patient's reactions. The pathological preoccupations with body function of a bizzare nature disappeared almost completely after 10 days and she began to take a very vigorous and assertive part in the hospital activities from which she had completely withdrawn before. Her appetite increased and her energy output was much greater. She became far less demanding and the difference was commented upon by many observers. On her return home from a weekend pass she stated that she had done more work in the house than she had been able to do in the past year. She was left on a maintenance dose of 75 mgm per day and has gained 20 pounds and reports that she feels "better than I have in 10 years". Follow-up five months later shows no signs of recurrence.
Case 5. Mrs. S.V. This 37-year-old housewife was referred because of almost constant frontal headache of two years' duration with no neurological or other somatic findings. It would appear that this patient has all her life been involved in situations giving rise to anger which she could not tolerate within herself. She has dealt with these conflicts both by suppression and repression of hostility. She has a neurotic need to please and to be "strong". She has felt discouraged and depressed but there were no suicidal thoughts. She was treated psychotherapeutically and placed on G 22355 in an attempt to cope with some of the depressive features. Response to the drug was to all intents and purposes nil. It would appear, in this patient, that environmental circumstances and the mechanisms of defence were such that a chemical approach to the affective disturbance would not be possible. After two months the drug was discontinued and the patient's' symptoms were unaltered.
SIDE EFFECTS
We feel the problem of side effects to be one which merits serious consideration; so frequent, indeed, were side effects of one type or another that fewer than 10% of patients were completely free of these. It is true that many reactions were of a minor nature and presumably due to the atropine-like action of the drug. Hence one would (as with chlorpromazine) expect that inherent in the pharmacological action of the drug would be development of certain reactions which are so common as to be almost routine. These include such complaints as dry mouth, increased or excessive sweating, constipation, mild to marked postural hypotension, and transient disturbances of accommodation.
These reactions, in mild form, while initially disturbing to the patient, are reasonably well tolerated by most individuals, especially if accompanied by concomitant alleviation of depressive symptomatology and an explanation by the therapist of their nature. In more severe form they may be quite incapacitating and extreme caution must be used in prescribing the initial dose of this drug, especially on an out patient basis where measures for observation and control may be quite difficult to set up.
LABORATORY STUDIES
All hospital patients and the initial group of out patients were given serial alkaline phosphatase determinations along with serial white blood cell and differential counts. It is interesting to note that .no patient in this series showed any pathological elevation of alkaline phosphatase level. Of the tested group, over 50% showed an elevation of the white blood cell count, usually in the range of 10 to 20 thousand, but 15% of the tested group showed elevations above 20 thousand. No consistent pattern emerged in this regard; the elevation of white cells was usually transient and corrected within two weeks or so. The same findings pertained to the Eosinophilia which was noted in about 10% of cases, again apparently as a transient phenomenon. What the long range pattern will be in this regard cannot be stated as yet.
EFFECT ON BLOOD PRESSURE
Blood pressure determinations were taken daily on the hospitalized group. Two-thirds of this group showed a hypotensive response of at least 10 mm Hg. This figure does not include a considerable percentage who showed an initial fall in blood pressure which later (usually in two to three days) corrected itself. It is our feeling that this hypotensive effect is one of the more important actions of this drug and, while apparently beneficial per se in some patients and without ill effects in most patients, may be implicated in some of our more serious reactions.
In some cases the blood pressure fall was quite dramatic, (up to 100 mm Hg); even without such a steep decline several patients showed initial shock-like symptoms.
We feel that this hypotensive effect should make one use extreme caution in administering this drug to people in whom a well-marked and prolonged blood pressure fall might lead to serious complications, for example in patients with a history of cerebro-vascular ischemia or of cardiac decompensation or coronary insufficiency. While we have no definitely proven relationship in our cases, there is reason at least to suspect that the one death in our series (from a massive pulmonary embolus in a 63-year-old man) and two deaths (by coronary thrombosis) not in this series but seen at another hospital, may have been on this basis. Ankle oedema was noted in two further patients, one of whom was able, with digitalization, to continue the drug; in the other patient the drug had to be discontinued.
CONSTIPATION
This effect may be somewhat difficult to assess as this is a well-known feature in many depressed individuals. Nevertheless in our patients this seemed to be more marked and less tractable to the usual laxative medications. We found this effect to be of considerable therapeutic value in cases where diarrhoea as a response to stress had been a chronic feature and practically unresponsive to other drugs. On the other hand however, one woman in our group developed, after complaining of severe constipation for some three weeks, signs and symptoms of abdominal obstruction. Surgical intervention revealed the presence of an umbilical herniation. It was postulated that the constipation, with its increased straining at stool, may have sufficiently raised intra-abdominal pressure to produce a herniation through an already weakened abdominal wall.
SKIN
Dermatological complications occurred in five cases (7%). These did not appear related to photosensitivity. The rash was usually macular in nature with widespread distribution, (back, neck, shoulders, arms and legs) and frequently itchy. One urticaria-like reaction was seen and one patient showed an exfoliative type of dermatitis. In the less troublesome rashes, the drug could be continued along with the usual anti-histamine treatment and local applications. The more severe reactions would seem to call for a discontinuation of the drug.
IMMEDIATE INTOLERANCE
Two patients had to be withdrawn from the drug after only two days' medication. Both stated they felt "completely overwhelmed" by the drug, with very marked dizziness, severe palpitations, jerky movements, and markedly increased tension and agitation on the usual initial dosage scale.
OTHER REACTIONS
One well-defined withdrawal reaction was noted in our series; another was reported to us in a personal communication and is noted here. Chief symptoms were nausea, vomiting, dizziness, chills, and great anxiety. Possibly more reactions of this type would have been seen if abrupt withdrawal of the drug had been more. frequent.
A toxic psychosis with hallucinations and delusions was seen in one patient after one week of administration of the drug. This subsided on discontinuation of the drug. Another such reaction has been reported in a patient treated by another psychiatrist.
COMMENT
On the basis of our experience to date with this drug we feel that it is possible to say that Imipramine represents a significant advance in the treatment of depressive illnesses. We are in agreement with previous workers who state that its maximum efficacy is in the group of people classically described as having "endogenous depressions".
The determination of the site and mechanism of action of this drug would seem to us to be the most important next step in its investigation. Obviously it is not within this paper's scope to do so except to say that we share the view that the whole problem of the depressive illnesses is a far more complex field than earlier views would have led us to believe. Perhaps a complete re-examination of our concepts is needed, along with an attempt at integration of the psychological, chemical, and neurophysiological data now available. Another important aspect for further work with this drug would be an intensive study of a relatively small number of cases in terms of the action of the drug on specific areas of psychopathology and psychodynamics. Studies to date have concentrated on the accumulation of data as to its efficacy as a treatment agent. This now appears reasonably well established and in our opinion more refined and morel detailed techniques may now be indicated.
